Indicated for: herpes zoster
Substance: brivudine (antiviral)
ATC: J05AB15 (Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors)
Brivudinum is an antiviral medication used for the treatment of varicella-zoster virus (VZV) infections, particularly in patients with shingles. It works by inhibiting viral replication, reducing the severity and duration of symptoms.
The medication is taken orally, usually once daily, as directed by a doctor. Treatment should be started as soon as possible after symptom onset to be effective.
Common side effects include nausea, headache, and fatigue. In rare cases, allergic reactions or liver function impairment may occur, requiring close monitoring of patients.
Brivudinum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.